Selected article for: "admission onset and lower higher"
Author: Zhenhua Zeng; Tong Sha; Yuan Zhang; Feng Wu; Hongbin Hu; Haijun Li; Jiafa Han; Wenhong Song; Qiaobing Huang; Zhongqing Chen
Title: Hypertension in patients hospitalized with COVID-19 in Wuhan, China: A single-center retrospective observational study
  • Document date: 2020_4_11
    • ID: lujxql3a_25
    Snippet: is the (which was not peer-reviewed) The copyright holder for this preprint . https://doi.org/10.1101/2020.04.06.20054825 doi: medRxiv preprint hypertension. Compared to patients without hypertension, patients with hypertension were significantly older and more likely to have underlying comorbidities, including chronic renal insufficiency, cardiovascular disease, diabetes mellitus, and cerebrovascular disease. Patients with hypertension tended to.....
    Document: is the (which was not peer-reviewed) The copyright holder for this preprint . https://doi.org/10.1101/2020.04.06.20054825 doi: medRxiv preprint hypertension. Compared to patients without hypertension, patients with hypertension were significantly older and more likely to have underlying comorbidities, including chronic renal insufficiency, cardiovascular disease, diabetes mellitus, and cerebrovascular disease. Patients with hypertension tended to have a longer time from onset to admission and have higher positive COVID-19 PCR detection rates. Table 2 shows the results of the laboratory tests performed on admission according to hypertension status. Patients with hypertension had higher levels of serum creatinine (SCr) and lower levels of hemoglobin and D-dimer in whole blood than patients without hypertension. No differences in clinical outcomes were found between patients with hypertension and without hypertension ( Table 3) .

    Search related documents:
    Co phrase search for related documents
    • cardiovascular disease and chronic renal insufficiency: 1, 2, 3, 4, 5
    • cardiovascular disease and clinical outcome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • cardiovascular disease and detection rate: 1, 2, 3, 4
    • cardiovascular disease and high level: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • cardiovascular disease and higher positive pcr detection rate: 1
    • cardiovascular disease and hypertension patient: 1, 2, 3, 4, 5, 6, 7
    • cardiovascular disease and hypertension status: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
    • cardiovascular disease and laboratory test: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21
    • cerebrovascular disease and chronic renal insufficiency: 1, 2, 3
    • cerebrovascular disease and clinical outcome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • cerebrovascular disease and detection rate: 1
    • cerebrovascular disease and high level: 1, 2, 3, 4, 5
    • cerebrovascular disease and higher positive pcr detection rate: 1
    • cerebrovascular disease and laboratory test: 1, 2
    • chronic renal insufficiency and detection rate: 1
    • chronic renal insufficiency and higher positive pcr detection rate: 1
    • chronic renal insufficiency and hypertension status: 1
    • clinical outcome and hypertension status: 1, 2, 3, 4, 5, 6
    • clinical outcome and laboratory test: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16